Helen-Maria Vasiliadis1, Fatoumata Binta Diallo2, Louis Rochette3, Mark Smith4, Donald Langille5, Elizabeth Lin6, Steve Kisely7,8, Eric Fombonne9, Angus H Thompson10, Johanne Renaud11, Alain Lesage12. 1. 1 University of Sherbrooke, Faculty of Medicine and Health Sciences, Research Center-Hôpital Charles LeMoyne, Longueuil, Québec. 2. 2 Bureau d'information et d'études en santé des populations, Institut national de santé publique du Québec, Québec City, Québec. 3. 3 Institut National de Santé Publique du Québec, Québec. 4. 4 Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba. 5. 5 Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia. 6. 6 Department of Psychiatry, Centre for Addiction and Mental Health, Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario. 7. 7 School of Medicine, The University of Queensland, Queensland, Australia. 8. 8 Departments of Psychiatry, Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia. 9. 9 Oregon Health and Sciences University, Portland, Oregon. 10. 10 Institute of Health Economics, Edmonton, Alberta. 11. 11 Department of Psychiatry, CIUSSS Douglas Mental Health University Institute, McGill University, Montreal, Québec. 12. 12 Université de Montréal, Institut Universitaire de Santé Mentale Montréal, Montréal, Québec.
Abstract
OBJECTIVE: There is a need for the routine monitoring of treated attention-deficit hyperactivity disorder (ADHD) for timely policy making. The objective is to report and assess over a decade the prevalence and incidence of diagnosed ADHD in Canada. METHODS: Administrative linked patient data from the provinces of Manitoba, Ontario, Quebec, and Nova Scotia were obtained from the same sources as the Canadian Chronic Diseases Surveillance Systems to assess the prevalence and incidence of a primary physician diagnosis of ADHD ( ICD-9 and ICD-10 codes: 314, F90.x) for consultations in outpatient and inpatient settings (Med-Echo in Quebec, the Canadian Institute of Health Information Discharge Abstract Database in the 3 other provinces, plus the Ontario Mental Health Reporting System). Dates of service, diagnosis, and physician specialty were retained. The estimates were presented in yearly brackets between 1999-2000 and 2011-2012 by age and sex groups. RESULTS: The prevalence of ADHD between 1999 and 2012 increased in all provinces and for all groups. The prevalence was approximately 3 times higher in boys than in girls, and the highest prevalence was observed in the 10- to 14-year age group. The incidence increased between 1999 and 2012 in Manitoba, Quebec, and Nova Scotia but remained stable in Ontario. Incident cases were more frequently diagnosed by general practitioners followed by either psychiatrists or paediatricians depending on the province. CONCLUSION: The prevalence and incidence of diagnosed ADHD did not increase similarly across all provinces in Canada between 1999 and 2012. Over half of cases were diagnosed by a general practitioner.
OBJECTIVE: There is a need for the routine monitoring of treated attention-deficit hyperactivity disorder (ADHD) for timely policy making. The objective is to report and assess over a decade the prevalence and incidence of diagnosed ADHD in Canada. METHODS: Administrative linked patient data from the provinces of Manitoba, Ontario, Quebec, and Nova Scotia were obtained from the same sources as the Canadian Chronic Diseases Surveillance Systems to assess the prevalence and incidence of a primary physician diagnosis of ADHD ( ICD-9 and ICD-10 codes: 314, F90.x) for consultations in outpatient and inpatient settings (Med-Echo in Quebec, the Canadian Institute of Health Information Discharge Abstract Database in the 3 other provinces, plus the Ontario Mental Health Reporting System). Dates of service, diagnosis, and physician specialty were retained. The estimates were presented in yearly brackets between 1999-2000 and 2011-2012 by age and sex groups. RESULTS: The prevalence of ADHD between 1999 and 2012 increased in all provinces and for all groups. The prevalence was approximately 3 times higher in boys than in girls, and the highest prevalence was observed in the 10- to 14-year age group. The incidence increased between 1999 and 2012 in Manitoba, Quebec, and Nova Scotia but remained stable in Ontario. Incident cases were more frequently diagnosed by general practitioners followed by either psychiatrists or paediatricians depending on the province. CONCLUSION: The prevalence and incidence of diagnosed ADHD did not increase similarly across all provinces in Canada between 1999 and 2012. Over half of cases were diagnosed by a general practitioner.
Entities:
Keywords:
ADHD; data linkage; diagnosis; surveillance; temporal trends
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Florence Levy; David A Hay; Kellie S Bennett; Michael McStephen Journal: J Am Acad Child Adolesc Psychiatry Date: 2005-04 Impact factor: 8.829
Authors: Ceara Tess Cunningham; Nathalie Jetté; Bing Li; Ravneet Robyn Dhanoa; Brenda Hemmelgarn; Tom Noseworthy; Cynthia A Beck; Elijah Dixon; Susan Samuel; William A Ghali; Carolyn DeCoster; Hude Quan Journal: CMAJ Open Date: 2015-10-02
Authors: J Biederman; S V Faraone; E Mick; S Williamson; T E Wilens; T J Spencer; W Weber; J Jetton; I Kraus; J Pert; B Zallen Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-08 Impact factor: 8.829
Authors: Charlotte Waddell; David R Offord; Cody A Shepherd; Josephine M Hua; Kimberley McEwan Journal: Can J Psychiatry Date: 2002-11 Impact factor: 4.356
Authors: Tamara J Sussman; Brennan H Baker; Albert J Wakhloo; Virginie Gillet; Nadia Abdelouahab; Kevin Whittingstall; Jean-François Lepage; Lindsay St-Cyr; Amélie Boivin; Anthony Gagnon; Andrea A Baccarelli; Larissa Takser; Jonathan Posner Journal: Environ Res Date: 2021-12-22 Impact factor: 6.498
Authors: Shantala A Hari Dass; Kathryn McCracken; Irina Pokhvisneva; Lawrence M Chen; Elika Garg; Thao T T Nguyen; Zihan Wang; Barbara Barth; Moein Yaqubi; Lisa M McEwen; Julie L MacIsaac; Josie Diorio; Michael S Kobor; Kieran J O'Donnell; Michael J Meaney; Patricia P Silveira Journal: EBioMedicine Date: 2019-03-26 Impact factor: 8.143
Authors: Rachael Morkem; Kenneth Handelman; John A Queenan; Richard Birtwhistle; David Barber Journal: BMC Med Inform Decis Mak Date: 2020-07-20 Impact factor: 2.796
Authors: Amanda Leanne Butler; Mark Smith; Wayne Jones; Carol E Adair; Simone N Vigod; Alain Lesage; Paul Kurdyak Journal: Int J Popul Data Sci Date: 2018-09-21